Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1387923

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1387923

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isothermal nucleic acid amplification technology (inapt) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inapt)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The isothermal nucleic acid amplification technology (inapt) market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Instrument; Reagent
  • 2) By Technology: NASBA; HAD
  • 3) By Application: Blood Screening; Infectious Disease Diagnostics; Cancer
  • 4) By End-User: Hospital; Reference Laboratories; Other End-Users
  • Companies Mentioned: Alere Inc.; biomatrix SA; Qiagen NV; Becton, Dickson & Company; Hologica Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Isothermal nucleic acid amplification technology (INAAT) is a method employed for amplifying DNA samples. INAAT enables the amplification of DNA sequences from two different nucleic acid segments at a constant temperature.

The primary product types associated with isothermal nucleic acid amplification technology include instruments and reagents. Reagents are substances or compounds introduced into a system to induce a chemical reaction or to determine whether a reaction has occurred. Various technologies, such as NASBA and HAD, are used in this context and are typically applied in areas like blood screening, infectious disease diagnostics, and cancer-related analyses. The end users of this technology encompass hospitals, reference laboratories, and other institutions.

The isothermal nucleic acid amplification technology (INAAT) market research report is one of a series of new reports from The Business Research Company that provides isothermal nucleic acid amplification technology (INAAT) market statistics, including isothermal nucleic acid amplification technology (INAAT) industry global market size, regional shares, competitors with a isothermal nucleic acid amplification technology (INAAT) market share, detailed isothermal nucleic acid amplification technology (INAAT) market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (INAAT) industry. This isothermal nucleic acid amplification technology (INAAT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isothermal nucleic acid amplification technology (inaat) market size has grown rapidly in recent years. It will grow from $3.53 billion in 2023 to $3.91 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed during the historical period can be attributed to several key factors, including the increased demand for infectious disease diagnostics, the expansion of point-of-care testing (POCT) solutions, efforts to control tuberculosis, advancements in molecular diagnostics, and the growing presence of these technologies in emerging markets. These factors collectively contributed to the growth in this period.

The isothermal nucleic acid amplification technology (inaat) market size is expected to see rapid growth in the next few years. It will grow to $6.39 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forecast period can be attributed to various key factors, including increased focus on pandemic preparedness, addressing the challenges of antimicrobial resistance, growing importance of environmental monitoring, advancements in oncology diagnostics, and the impact of global health initiatives. Notable trends expected to shape this period include the adoption of multiplexing techniques, miniaturization of technologies, digital detection methods, the development of sample-to-answer systems, and the integration of gene editing technologies, reflecting the evolving landscape of isothermal nucleic acid amplification technology.

The rising incidence of Infectious and Chronic Diseases is a significant driver behind the expansion of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. Diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are on the increase, demanding diagnostic solutions like isothermal nucleic acid amplification technology (INAAT). According to the World Health Organization (WHO), an estimated 10 million people contract tuberculosis every year, resulting in 1.5 million deaths. The growing prevalence of infectious and chronic diseases is a key factor fueling the expansion of the isothermal nucleic acid amplification technology market.

Government initiatives aimed at healthcare research and development are poised to significantly drive the growth of the isothermal nucleic acid amplification technology market in the future. These initiatives involve specific actions, programs, or policies launched by government entities to tackle various healthcare issues, including supporting isothermal nucleic acid amplification technology. In 2022, the UK's Department of Health and Social Care (DHSC) announced a £260 million ($270.65 million) funding commitment to foster healthcare research and manufacturing. This funding, established by the Department for Business, Energy and Industrial Strategy (BEIS) and DHSC, aims to facilitate NHS-led health research, privacy-preserving platforms for diagnostics and treatments, and bolster life sciences manufacturing in the UK. Hence, government initiatives focused on healthcare research and development are propelling the isothermal nucleic acid amplification technology market.

The market for isothermal nucleic acid amplification technology faces strict regulations imposed by stringent policies governing the operations, approvals, and manufacturing standards of this sector. These regulatory policies act as a deterrent for companies looking to invest in new product research and development or expand into new markets. For instance, the US Food and Drug Administration (USFDA) mandates a multi-laboratory validation process for loop-mediated isothermal amplification, which takes twice as long as the review process by the European regulatory body. Prolonged regulatory procedures delay further exploration of device safety and efficacy studies, impacting vendor operating cycles and subsequently hindering market growth.

Nanostructures are increasingly integrated into in vitro diagnostics and in vitro rapid diagnostic tests (RDTs) to enhance existing tests' effectiveness and develop innovative diagnostic approaches for point-of-care applications. Nanostructures and nanotechnology employ nanoparticles to improve drug actions in treatments. Nanotechnology entails designing, characterizing, producing, and applying devices, structures, and systems by precisely manipulating size and shape at the nanometer scale. Several RDTs have been created for syphilis diagnosis, such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs enable patients to receive diagnoses at the point of care (POC).

Major companies operating in the isothermal nucleic acid amplification technology market are developing innovative solutions like the QIAstat-Dx syndromic testing solution to gain a competitive advantage. The QIAstat-Dx system is an integrated, multiplexed molecular testing platform that combines sample preparation, nucleic acid amplification, and detection within a single cartridge. For instance, in April 2023, Qiagen, a Netherlands-based company specializing in isothermal nucleic acid amplification technology (INAAT) for various applications, introduced the QIAstat-Dx syndromic testing solution. This system provides Ct (cycle threshold) values and access to amplification curves, allowing clinicians to monitor amplification progress and make well-informed diagnostic decisions.

In July 2021, Sapphiros, a KKR-backed platform focused on advancing the next generation of diagnostic technologies, acquired Biocrucible Ltd. for an undisclosed sum. This acquisition aimed to establish leading consumer molecular diagnostics in the market. Biocrucible Ltd., a UK-based biotechnology company, is known for accelerating and enhancing biochemical kinetics through its Molten TagsTM technology.

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market include Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2023. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the isothermal nucleic acid amplification technology (inaat) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9165

Table of Contents

1. Executive Summary

2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics

3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends And Strategies

4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Growth

  • 5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

  • 6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instrument
  • Reagent
  • 6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • NASBA
  • HAD
  • 6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • 6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Reference Laboratories
  • Other End-Users

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional And Country Analysis

  • 7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 18.5. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 19.9. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 20.13. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 21.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 21.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 22.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 23.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 23.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 24.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 24.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 25.1. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 25.2. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 26.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 26.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 27.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 28.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 28.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 29.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 29.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape And Company Profiles

  • 30.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
  • 30.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
    • 30.2.1. Alere Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. biomeriux SA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Qiagen NV
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickson & Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hologica Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Benchmarking

32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

34. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Future Outlook and Potential Analysis

  • 34.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!